Abstract Background The relationship between obstructive sleep apnea syndrome (OSAS) and pulmonary embolism (PE) remains inadequately characterized, and prospective data obtained with objective sleep testing in confirmed PE patients are scarce. We aimed to determine the prevalence of OSAS in patients with radiologically confirmed PE and to compare clinical, laboratory, and polysomnographic features according to OSAS status. Methods In this single-center prospective observational study, 45 patients with confirmed PE (thoracic computed tomography pulmonary angiography or ventilation/perfusion scintigraphy) underwent portable polysomnography (WatchPAT 200 ® ) within two weeks of diagnosis. OSAS was defined as an apnea–hypopnea index (AHI) ≥ 5 events/hour. Group comparisons used the Mann–Whitney U test and chi-square or Fisher’s exact test; associations with AHI were assessed by Spearman’s rank correlation. Results OSAS was identified in 31 patients (68.9%): 11 mild, 12 moderate, and 8 severe. Body mass index (BMI) was significantly higher in OSAS-positive patients median 31.2 (IQR 26.5–34.6) vs. 27.3 (24.2–30.4) kg/m²; p = 0.037. Blood urea nitrogen was also elevated in the OSAS group 36.0 (25.1–52.0) vs. 19.5 (16.2–43.5) mg/dL; p = 0.026. Minimum nocturnal oxygen saturation was markedly lower in OSAS patients 83.0% (79.0–86.5) vs. 91.0% (88.5–92.0); p < 0.001, as were the oxygen desaturation index and time with SpO₂ <90% (both p < 0.001). AHI correlated positively with age ( r = 0.363; p = 0.014) and negatively with minimum nocturnal SpO₂ ( r =− 0.753; p < 0.001). Classical Wells criteria did not differ between groups; 38.7% of OSAS-positive patients had no identifiable Wells risk factor for PE. Conclusions OSAS was present in nearly 70% of PE patients and was associated with greater nocturnal hypoxemic burden, higher BMI, and elevated blood urea nitrogen. The absence of classical precipitating factors in a substantial proportion of OSAS-positive patients is consistent with the hypothesis that sleep-disordered breathing may be associated with an increased thrombotic risk. Further prospective studies are needed to evaluate the clinical utility and cost-effectiveness of targeted OSAS screening strategies in PE patients, particularly those without conventional risk factors.
Canbaz et al. (Sat,) studied this question.